Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. - Wikidata - wikimedia - TriplyDB

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

http://www.wikidata.org/entity/Q33852247

about

Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit.Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weigh Antimicrobial resistance: the example of Staphylococcus aureus Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model Screening of crude extracts of six medicinal plants used in South-West Nigerian unorthodox medicine for anti-methicillin resistant Staphylococcus aureus activity Clinical review: use of vancomycin in haemodialysis patients Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.Myeloid-Derived Suppressor Cells in Bacterial Infections Mechanisms of vancomycin resistance in Staphylococcus aureus Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections Crystal structure of the enzyme CapF of Staphylococcus aureus reveals a unique architecture composed of two functional domains Crystal structure of the capsular polysaccharide synthesizing protein CapE of Staphylococcus aureus Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery Vancomycin-intermediate Staphylococcus aureus in a home health-care patient In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective Modeling of the bacterial mechanism of methicillin-resistance by a systems biology approach Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus Evaluation of the AdvanDx VRE EVIGENE assay for detection of vanA in vancomycin-resistant Staphylococcus aureus Production of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from phoomdi in Loktak Lake of Manipur, India.Mapping ultra-weak protein-protein interactions between heme transporters of Staphylococcus aureus Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria.Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus.Targeted photodynamic therapy of established soft-tissue infections in mice Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia.Linezolid-Induced anemia and thrombocytopenia.Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

P2860

Q24247771-2974CED3-AA01-4591-9FF9-F2F96CC3B2BC Q24532922-E54E4569-6037-4C09-8727-67CE3968D1DF Q24595714-DBACF6F0-D347-4D28-9507-9F26EBB1022C Q24646677-7F88921F-06C7-418C-8689-BC44CB63FF8D Q24654724-947CC1DC-A1E7-4DE9-8519-A566402F86A1 Q24676363-3859A85A-C84E-475E-82F6-C653E6607759 Q24682172-033E068E-7DD4-4651-8C61-A86980419D83 Q24792368-97ECF7E0-5093-4128-9134-7DF4E8CAEF24 Q24796940-04F86664-835A-4F3E-8AA2-F9CE83B77513 Q24813204-E5877BA9-0A1A-4077-BAE6-EAE6602203EE Q26749373-FF8C4164-D072-4FE1-8AF9-37D8E7B6EDDC Q26829312-C1AEF28C-D808-4103-A462-CEAC1B3C774B Q26853612-F678735F-957A-4971-AB36-763D33E3BCFA Q27677173-33431D33-C664-4E5A-A583-54F768AD601A Q27677521-12726757-06A5-44DE-9203-10C6B59EF190 Q27685283-56E757A2-84CD-43FF-BBE8-7F8FA58FB99D Q27702303-DD8CFCF3-90FB-44CC-B6E6-034C9C894158 Q28344792-55BD5B90-2583-4124-8ED6-1BC8A242E3FA Q28362193-79023317-6E15-4614-917F-D72538183199 Q28366610-53574D1C-415B-45AC-AA6D-BF87BFD3E006 Q28366629-4A673A37-17FB-49E9-B3D2-882FCF88F984 Q28385700-94FFB6AB-7493-4DCA-8823-4E93B3BD86F2 Q28388806-29A93484-C70D-4B3A-87E4-1CA001BB1398 Q28475777-D889DD7E-9083-447A-9A3D-F954F1041DCD Q28477900-718A9F9C-9F96-497E-BD70-B3919239B22A Q29619365-2676C2EA-385C-49DD-B025-02E9B2A87188 Q30230055-CA9A510B-563B-4340-8349-AF8E2BA30C98 Q30390187-DED49A64-3324-43CE-AE60-0E46193224A6 Q30514059-F0796AD6-EC02-4630-9B25-D95737801BB3 Q30725913-F5DCEE95-A4F0-403E-8A4B-256CC4A7F05B Q31050150-D39F1760-617D-4B28-8780-21F584548E17 Q31056358-C550E4A5-5974-497F-85B7-671BA318D3DC Q31372845-784B1B77-D345-4819-86B0-4B42E2BB70B7 Q31704853-5590B373-AA03-45F3-AF2C-161E722182AB Q32092345-BF5F7ED5-F352-4453-853F-0C0471B56E6C Q33261667-7AA91233-215B-4B37-9E95-B84EC43BBCEF Q33264579-2126FB3A-67DC-4718-908D-A1AA8FBBA487 Q33290348-04396EB7-10F1-4A3A-8136-3141C9057C87 Q33340618-C2A0196B-BD6D-4179-8FE4-F18CD873471F Q33460707-6E693861-A815-40EC-8CDB-310223E55BF2

P2860

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

http://www.wikidata.org/entity/Q33852247

description

1999 nî lūn-bûn

@nan

1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Emergence of vancomycin resist ...... lococcus aureus Working Group.

@ast

Emergence of vancomycin resist ...... lococcus aureus Working Group.

@en

type

label

Emergence of vancomycin resist ...... lococcus aureus Working Group.

@ast

Emergence of vancomycin resist ...... lococcus aureus Working Group.

@en

prefLabel

Emergence of vancomycin resist ...... lococcus aureus Working Group.

@ast

Emergence of vancomycin resist ...... lococcus aureus Working Group.

@en

P1433

Q33852247-43609150-A923-45B7-89C1-D6FA6B5E4842

P1476

Q33852247-11E4754C-5082-4133-9954-A1D89EAA9EB0

P2093

Q33852247-09406173-6073-4A79-B005-C3A5BAF7D97E

Q33852247-518A6DF4-30EC-4E60-A797-DE77F49F25AE

Q33852247-78DBB420-8421-4AA7-BBB3-4AB871B9B165

Q33852247-79C4ACEA-5498-4E69-A8F9-0105056CA98E

Q33852247-84A56DCD-96EE-4C0E-B75A-E2079515F9B9

Q33852247-ABE2E1D8-B652-4042-983E-33CF66D8CCCE

Q33852247-BF5BBA50-49ED-4BBE-BEB9-78E4AA42A03A

Q33852247-DA207E26-EE00-47C8-B3CB-3CCDFF68D519

Q33852247-E08CBCDC-2392-46B7-B320-EF295ECB817C

Q33852247-E3996107-6E6F-4AC3-803C-A8AA69649A70

P304

Q33852247-4B86950E-7CA6-4477-972F-BDCCE3E39E32

P31

Q33852247-FFC10C14-2718-403A-9E00-96A0D2D335AF

P356

Q33852247-9D091D1F-52D7-43D2-9C33-B312EA9E0ECC

P407

Q33852247-7BA0D89F-EB18-4147-BB3E-A126E4C4D629

P433

Q33852247-4ED89BE4-B68D-4785-B998-9AD4E6CF5C40

P478

Q33852247-27490CD7-46A5-4375-95E1-5405C696079A

P577

Q33852247-B3887309-6B49-438C-8AA8-AB980B310240

P698

Q33852247-EA7365C0-F115-46A2-8C1C-4872949BD072

P356

NEJM199902183400701

P1433

The New England Journal of Medicine

P1476

Emergence of vancomycin resist ...... lococcus aureus Working Group.

@en

P2093

Band JD

http://www.w3.org/2001/XMLSchema#string

Cruz C

http://www.w3.org/2001/XMLSchema#string

Jarvis WR

http://www.w3.org/2001/XMLSchema#string

Lancaster MV

http://www.w3.org/2001/XMLSchema#string

Pearson ML

http://www.w3.org/2001/XMLSchema#string

Robinson-Dunn B

http://www.w3.org/2001/XMLSchema#string

Smith TL

http://www.w3.org/2001/XMLSchema#string

Tenover FC

http://www.w3.org/2001/XMLSchema#string

White E

http://www.w3.org/2001/XMLSchema#string

Wilcox KR

http://www.w3.org/2001/XMLSchema#string

P304

493-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199902183400701

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

340

http://www.w3.org/2001/XMLSchema#string

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10021469

http://www.w3.org/2001/XMLSchema#string